IMAG±iNe 2.0 study: How biomarkers could help researchers better understand IgM-associated PN 

Interview with Perry van Doormaal, MD, PhD  In this interview, Amanda Homscheid, FPN Program Manager, speaks with Perry van Doormaal, MD, PhD, a Senior Researcher at the University Medical Center Utrecht in the Netherlands and Principal Investigator of the IMAG±iNe study. This study focuses on a rare nerve disease called IgM-associated peripheral neuropathy, which can happen with or without something called anti-MAG antibodies.  In this interview, Dr. van Doormaal talks about a new study that builds on what researchers learned from the original IMAG±iNe study. […]

Read More… from IMAG±iNe 2.0 study: How biomarkers could help researchers better understand IgM-associated PN 

A powerful new study to predict progression and improve care in anti-MAG neuropathy

We are proud to announce that with the help from generous donors, the Foundation for Peripheral Neuropathy is funding an important new research study. We are investing $525,000 over the next three years to support this work. This project brings hope to people living with IgM peripheral neuropathy (IgM-PNP), also including anti-MAG neuropathy. It is a rare nerve disease that can be very unpredictable.  […]

Read More… from A powerful new study to predict progression and improve care in anti-MAG neuropathy

FPN welcomes the Brigham and Women’s Hospital as a new site for the IMAGiNe Study 

The Foundation for Peripheral Neuropathy (FPN) is excited to share that the Brigham and Women’s Hospital has joined the IMAGiNe Study as a new research site. With help from FPN, they will take part in this international study about IgM anti-MAG peripheral neuropathy, a rare autoimmune form of PN.  About the IMAGiNe Study  The IMAGiNe Study (IgM Anti-Myelin-Associated Glycoprotein Neuropathy Study) is led by Maastricht University Medical Center in the Netherlands. The study is creating a […]

Read More… from FPN welcomes the Brigham and Women’s Hospital as a new site for the IMAGiNe Study 

IMAGiNe study progress: 2025 highlights and what’s ahead

As we start a new year, we are excited to look back at what the IMAGiNe study achieved in 2025. We are also looking ahead to our goals for 2026 and beyond. At the Foundation for Peripheral Neuropathy (FPN), we celebrate every milestone that helps move peripheral neuropathy research forward.   About the IMAGiNe study  The IMAGiNe study (IgM Anti-Myelin-Associated Glycoprotein Neuropathy Study) is led by Maastricht University Medical […]

Read More… from IMAGiNe study progress: 2025 highlights and what’s ahead

FPN welcomes The Ohio State University as a new site for the IMAGiNe Study

The Foundation for Peripheral Neuropathy (FPN) is excited to share that The Ohio State University (OSU) has joined the IMAGiNe Study as a new research site. With help from FPN, OSU will take part in this international study about IgM anti-MAG peripheral neuropathy, a rare and often misunderstood nerve disease. About the IMAGiNe Study The […]

Read More… from FPN welcomes The Ohio State University as a new site for the IMAGiNe Study